EMTA Holdings, Inc. and Subsidiaries
Consolidated Balance Sheets
| | March 31, | | | March 31, | |
ASSETS | | 2008 | | | 2007 | |
| | | | | | |
Current Assets: | | | | | | |
Cash | | $ | 59,544 | | | $ | 101,116 | |
Accounts receivable | | | 932,125 | | | | 67,571 | |
Notes receivable | | | 137,500 | | | | – | |
Inventory | | | 416,793 | | | | 586,453 | |
Prepaid expenses | | | 62,849 | | | | 28,304 | |
Total Current Assets | | | 1,608,811 | | | | 783,444 | |
Property, plant and equipment, net of accumulated depreciation | | | 1,786,967 | | | | 2,035,908 | |
Other Assets: | | | | | | | | |
Other assets | | | 2,351 | | | | 12,156 | |
Intangible assets | | | 633,611 | | | | 760,333 | |
Total Other Assets | | | 635,962 | | | | 772,489 | |
Total Assets | | $ | 4,031,740 | | | $ | 3,591,841 | |
| | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | |
| | | | | | | | |
Current Liabilities: | | | | | | | | |
Accounts payable | | $ | 815,932 | | | $ | 640,852 | |
Accrued liabilities | | | 1,657,416 | | | | 1,396,063 | |
Cashless warrant liability | | | 257,379 | | | | 58,283 | |
Notes payable and amounts due within one year | | | 1,795,398 | | | | 1,989,693 | |
Conversion share derivative liability | | | – | | | | 2,305,999 | |
Total Current Liabilities | | | 4,526,126 | | | | 6,390,890 | |
Notes payable due after one year | | | 874,698 | | | | – | |
Conversion share derivative liability | | | 2,362,815 | | | | – | |
Total Liabilities | | | 7,763,639 | | | | 6,390,890 | |
Stockholders' Equity | | | | | | | | |
Preferred Stock, $0.001 par value, 1,000,000 authorized; | | | | | | | | |
no shares issued and outstanding | | | – | | | | – | |
Common Stock, $0.001 par value, 250,000,000 | | | | | | | | |
authorized, issued and outstanding 54,885.103 | | | | | | | | |
and 40,396,004 at March 31, 2008 and | | | | | | | | |
2007, respectively | | | 54,885 | | | | 40,396 | |
Additional paid-in capital | | | 23,267,228 | | | | 21,764,483 | |
Accumulated Deficit | | | (27,054,012 | ) | | | (24,603,928 | ) |
Total Stockholders' Equity | | | (3,731,899 | ) | | | (2,799,049 | ) |
Total Liabilities and Stockholders' Equity | | $ | 4,031,740 | | | $ | 3,591,841 | |
See accompanying notes to these consolidated financial statements.
Consolidated Statements of Operations
| | For the year ended March 31, | |
| | 2008 | | | 2007 | |
Revenue: | | | | | | |
Sales, net of returns and allowances | | $ | 2,769,949 | | | $ | 1,053,767 | |
Cost of sales | | | 1,305,328 | | | | 424,929 | |
| | | | | | | | |
Gross Profit | | | 1,464,621 | | | | 628,838 | |
| | | | | | | | |
Operating Expenses: | | | | | | | | |
Selling, general and administrative | | | 2,696,507 | | | | 2,931,090 | |
Depreciation and amortization | | | 247,768 | | | | 154,666 | |
Allowance for bad debts | | | 41 | | | | (15,476 | ) |
Research and development | | | 118,546 | | | | 304,793 | |
| | | | | | | | |
Total Operating Expenses | | | 3,062,862 | | | | 3,375,073 | |
| | | | | | | | |
Loss From Operations | | | (1,598,240 | ) | | | (2,746,235 | ) |
| | | | | | | | |
Other Income and (Expense): | | | | | | | | |
Other income | | | – | | | | 12,608 | |
Gain/(Loss) on disposal of assets | | | – | | | | 2,850 | |
Interest expense | | | (851,843 | ) | | | (364,932 | ) |
Cost of curing loan default | | | – | | | | (13,960,334 | ) |
| | | | | | | | |
Loss before provision for income taxes | | | (2,450,084 | ) | | | (17,056,043 | ) |
| | | | | | | | |
Provision for/(Benefit of) income taxes | | | – | | | | – | |
| | | | | | | | |
Net Loss | | $ | (2,450,084 | ) | | $ | (17,056,043 | ) |
| | | | | | | | |
Earning per share: | | | | | | | | |
Basic loss per share | | $ | (0.06 | ) | | $ | (0.54 | ) |
Weighted average shares outstanding | | | 44,490,994 | | | | 31,410,799 | |
See accompanying notes to these consolidated financial statements.
Consolidated Statements of Stockholders (Deficit)/Equity
| | Shares | | | Common Stock | | | Additional Paid-in Capital | | | Accumulated Deficit | | | Total | |
| | | | | | | | | | | | | | | |
Balance March 31, 2006 | | | 31,217,004 | | | $ | 31,217 | | | $ | 6,742,578 | | | $ | (7,547,885 | ) | | $ | (774,090 | ) |
| | | | | | | | | | | | | | | | | | | | |
Fractional shares issued on reverse acquisition | | | 4,000 | | | | 4 | | | | (4 | ) | | | | | | | | |
Fair value of loan cure at cure date | | | | | | | | | | | 13,960,334 | | | | | | | | 13,960,334 | |
Shares issued for acquisition of Dyson Properties, Inc. | | | 1,400,000 | | | | 1,400 | | | | 110,600 | | | | | | | | 112,000 | |
Shares issued for services of employees and others | | | 7,325,000 | | | | 7,325 | | | | 578,675 | | | | | | | | 586,000 | |
Shares issued on conversion of debt | | | 450,000 | | | | 450 | | | | 372,300 | | | | | | | | 372,750 | |
Net loss for the year ended March 31, 2007 | | | | | | | | | | | | | | | (17,056,043 | ) | | | (17,056,043 | ) |
| | | | | | | | | | | | | | | | | | | | |
Balance March 31, 2007 | | | 40,396,004 | | | | 40,396 | | | | 21,764,483 | | | | (24,603,928 | ) | | | (2,799,049 | ) |
| | | | | | | | | | | | | | | | | | | | |
Shares issued for cash | | | 9,050,000 | | | | 9,050 | | | | 1,106,262 | | | | | | | | 1,115,312 | |
Shares issued for services of employees and others | | | 4,239,099 | | | | 4,239 | | | | 297,483 | | | | | | | | 301,722 | |
Shares issued on conversion of debt | | | 1,200,000 | | | | 1,200 | | | | 99,000 | | | | | | | | 100,200 | |
Net loss for the year ended March 31, 2008 | | | | | | | | | | | | | | | (2,450,084 | ) | | | (2,450,084 | ) |
| | | | | | | | | | | | | | | | | | | | |
Balance March 31, 2008 | | | 54,885,103 | | | $ | 54,885 | | | $ | 23,267,228 | | | $ | (27,054,012 | ) | | $ | (3,731,899 | ) |
See accompanying notes to these consolidated financial statements.
Consolidated Statements of Cash Flows
| | For the year ended March 31, | |
| | 2008 | | | 2007 | |
Cash Flows from Operating Activities: | | | | | | |
Net Loss | | $ | (2,450,084 | ) | | $ | (17,056,043 | ) |
Adjustments to reconcile net loss to net cash | | | | | | | | |
used by operating activities: | | | | | | | | |
Depreciation and amortization | | | 247,768 | | | | 154,666 | |
Loss (gain) on sale of assets | | | – | | | | (2,850 | ) |
Bad debt provision | | | – | | | | (15,476 | ) |
Cost of curing loan default | | | – | | | | 13,960,334 | |
Amortization of debt discount | | | 295,050 | | | | 224,532 | |
Shares issued for services | | | 289,722 | | | | 84,000 | |
Stock grants to employees | | | 12,000 | | | | 502,000 | |
Cashless warrant conversion | | | 199,096 | | | | – | |
Changes in assets and liabilities, excluding | | | | | | | | |
effects of acquisitions: | | | | | | | | |
Accounts receivable | | | (864,554 | ) | | | 58,309 | |
Inventories | | | 169,660 | | | | (132,878 | ) |
Prepaids | | | (34,545 | ) | | | 9,731 | |
Other assets | | | 9,805 | | | | 5,219 | |
Accounts payable | | | 175,080 | | | | (365,585 | ) |
Accrued liabilities | | | 261,353 | | | | 108,257 | |
Cash provided (used) by operating activities | | | (1,689,649 | ) | | | (2,465,784 | ) |
| | | | | | | | |
Investing Activities: | | | | | | | | |
Capital expenditures | | | (12,089 | ) | | | (1,838,608 | ) |
Acquisitions of business | | | (119,760 | ) | | | 100,000 | |
Note receivable | | | (137,500 | ) | | | – | |
Cash used by investing activities | | | (269,349 | ) | | | (1,738,608 | ) |
Financing Activities: | | | | | | | | |
Net borrowings of short term debt | | | 1,413,442 | | | | 4,295,692 | |
Repayment of debt | | | (611,327 | ) | | | – | |
Net proceeds from issuance of common shares | | | 1,115,312 | | | | – | |
Net cash used by financing activities | | | 1,917,427 | | | | 4,295,692 | |
Net increase (decrease) in cash | | | (41,571 | ) | | | 91,300 | |
Cash at beginning of period | | | 101,116 | | | | 9,816 | |
Cash at end of period | | $ | 59,544 | | | $ | 101,116 | |
| | | | | | | | |
(Continued)
See accompanying notes to these consolidated financial statements.
Consolidated Statements of Cash Flows
(Continued)
| | For the year ended March 31, | |
| | 2008 | | | 2007 | |
Supplemental disclosures of cash flow information: | | | | | | | | |
| | | | | | | | |
Cash paid during the year for: | | | | | | | | |
Interest | | $ | 367,536 | | | $ | 70,302 | |
Income taxes | | $ | – | | | $ | – | |
| | | | | | | | |
Non Cash Activities: | | | | | | | | |
Notes payable converted to common stock | | $ | (100,200 | ) | | $ | (372,750 | ) |
Common stock issued for notes payable | | | 1,200 | | | | 450 | |
Additional paid-in capital from conversion of note payable | | | 99,000 | | | | 372,300 | |
| | $ | – | | | $ | – | |
See accompanying notes to these consolidated financial statements.
EMTA Holdings, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
For the Years Ended March 31, 2008 and 2007
The Company - EMTA Holdings, Inc. (which is referred to herein together with its subsidiaries as “Holdings”, ‘the Company”, "we", "us" or "our"), formerly Omni Alliance Group, Inc., was organized and incorporated in the state of Nevada. On March 31, 2006, we changed our name from Omni Alliance Group, Inc. to EMTA Holdings, Inc., and our common stock now trades on the OTC- Bulletin Board market under the trading symbol "EMHD.OB".
Nature of the Business - We are a specialty energy conservation chemical company that produces and supplies technologies to the global transportation, industrial and consumer markets. These technologies include gasoline, oil and diesel additives for engines and other transportation-related fluids and industrial lubricants.
Acquisitions and Mergers - Effective January 1, 2007 the Company has acquired Dyson Properties, Inc. Dyson manufactures and sells automotive racing and performance oils and lubricants under the name Synergyn Racing and also produces products under contract to third parties. The Synergyn line established in 1987 compliments the XenTx line and gives EMTA manufacturing and distribution capabilities from the Synergyn plant in Durant, OK.
This acquisition gives the Company the ability to manufacture, bottle and distribute its products through the Dyson location in Durant OK. We expect to expand distribution of both product lines through the cross marketing of each other’s products.
The aggregate purchase price is $2,100,000, to be paid in cash and stock. The initial payment of $100,000 was made on January 9, 2007. An additional $150,000 was paid on the Closing Date, July 5, 2007. The balance of $254,240 will be paid in July 2008. In addition, on March 26, 2007 the Company issued 1,400,000 shares of common stock to the seller and the right to 1,400,000 warrants to acquire a like number of shares on a cashless basis at an exercise price of $0.75 per share for a period of three years from the Closing Date. In addition, the Seller will be entitled to a royalty for all sales of the Synergyn products for five years at a rate of $0.20 per gallon or $0.20 per pound as the case may be, paid quarterly on the first $600,000 of royalties earned during the royalty term and $0.10 per gallon or per pound thereafter for the remainder of the royalty term. During the year ended March 31, 2008 the purchase price was adjusted by $119,760 pursuant to the Purchase Agreement
The purchase price was allocated to the fair market value of assets acquired and liabilities assumed as follows:
Cash and receivables | | $ | 22,122 | |
Inventory | | | 129,855 | |
Property and equipment | | | 1,893,151 | |
Total assets acquired | | | 2,045,128 | |
Total liabilities assumed | | | 1,371,112 | |
Net assets acquired | | $ | 674,016 | |
Continuance of Operations
These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The general business strategy of the Company is to develop products and operate its sales force and to acquire additional businesses. The Company has negative working capital, has incurred operating losses and requires additional capital to fund development activities, meet its obligations and maintain its operations. These conditions raise doubt about the Company's ability to continue as a going concern. The Company completed a private offering of its restricted common stock in April 2008 with the sale of 10,206,000 shares, with net proceeds to the Company of $1,211,962. Of this amount, $1,015,312 was received in the fourth quarter of 2008 and is included in these financial statements. The Company is in negotiations to obtain additional necessary capital to complete its regulatory approvals, expand production and sales and generally meet its business objectives. The company forecasts that the equity obtained and additional borrowing capacity will provide sufficient funds to complete its primary development activities and achieve profitable operations. Accordingly, these financial statements do not include any adjustments that might result from this uncertainty.
Note 2 - Significant Accounting Policies
Consolidation - The consolidated financial statements include the accounts of EMTA Holdings, Inc. and its consolidated subsidiaries and wholly-owned limited liability company. The financial statements for the year ended March 31, 2007 include the operations of Dyson Properties, Inc. since December 31, 2006. All significant intercompany transactions and profits have been eliminated.
Use of Estimates - The preparation of financial statements in conformity with United States generally accepted accounting principles requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. The more significant estimates relate to revenue recognition, contractual allowances and uncollectible accounts, intangible assets, accrued liabilities, derivative liabilities, income taxes, litigation and contingencies. Estimates are based on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for judgments about results and the carrying values of assets and liabilities. Actual results and values may differ significantly from these estimates.
Cash Equivalents - The Company invests its excess cash in short-term investments with various banks and financial institutions. Short-term investments are cash equivalents, as they are part of the cash management activities of the company and are comprised of investments having maturities of three months or less when purchased.
Allowance for Doubtful Accounts - The Company provides an allowance for doubtful accounts when management estimates collectibility to be uncertain. Accounts receivable are continually reviewed to determine which, if any, accounts are doubtful of collection. In making the determination of the appropriate allowance amount, the Company considers current economic and industry conditions, relationships with each significant customer, overall customer credit-worthiness and historical experience. The allowance for doubtful accounts was $34,149 at March 31, 2008 and 2007.
Inventories - Inventories are stated at the lower of cost or market value. Cost of inventories is determined by the first-in, first-out (FIFO) method. Obsolete or abandoned inventories are charged to operations in the period that it is determined that the items are not longer viable sales products.
Property, Plant, and Equipment - Plant and equipment are carried at cost. Repair and maintenance costs are charged against operations while renewals and betterments are capitalized as additions to the related assets. The Company depreciates its plant and equipment and computers on a straight line basis. Estimated useful life of the plant is 39.5 years and the equipment ranges from 3 to 10 years.
Intangible Assets - Intangible assets consist of patents, trademarks and government approvals. For financial statement purposes, identifiable intangible assets with a defined life are being amortized using the straight-line method over the estimated useful lives of the assets. Costs incurred by the Company in connection with patent, trademark applications and approvals from governmental agencies such as the Environmental Protection Agency, including legal fees, patent and trademark fees and specific testing costs, are expensed as incurred. Purchased intangible costs of completed developments are capitalized and amortized over an estimated economic life of the asset, generally seven years. commencing on the acquisition date. Costs subsequent to the acquisition date are expensed as incurred.
Impairment of Long-Lived Assets - In accordance with the Statement of Financial Accounting Standards No. 144 (“FAS 144”), “Accounting for the Impairment or Disposal of Long-Lived Assets,” the Company reviews long-lived assets, including, but not limited to, property and equipment, patents and other assets, for impairment annually or whenever events or changes in circumstances indicate the carrying amounts of assets may not be recoverable. The carrying value of long-lived assets is assessed for impairment by evaluating operating performance and future undiscounted cash flows of the underlying assets. If the sum of the expected future cash flows of an asset is less than its carrying value, an impairment measurement is required. Impairment charges are recorded to the extent that an asset’s carrying value exceeds fair value. Accordingly, actual results could vary significantly from such estimates. There were no impairment charges during the periods presented.
Fair Value Disclosures - The carrying values of cash, accounts receivable, deposits, prepaid expenses, accounts payable and accrued expenses generally approximate the respective fair values of these instruments due to their current nature.
The fair values of debt instruments for disclosure purposes only are estimated based upon the present value of the estimated cash flows at interest rates applicable to similar instruments.
The Company generally does not use derivative financial instruments to hedge exposures to cash flow or market risks. However, certain other financial instruments, such as warrants and embedded conversion features that are indexed to the Company’s common stock, are classified as liabilities when either (a) the holder possesses rights to net-cash settlement or (b) physical or net-share settlement is not within the control of the Company. In such instances, net-cash settlement is assumed for financial accounting and reporting, even when the terms of the underlying contracts do not provide for net-cash settlement. Such financial instruments are initially recorded at fair value and subsequently adjusted to fair value at the close of each reporting period.
Revenue Recognition - Revenues are recognized at the time of shipment of products to customers, or at the time of transfer of title, if later, and when collection is reasonably assured. All amounts in a sales transaction billed to a customer related to shipping and handling are reported as revenues.
Provisions for sales discounts and rebates to customers are recorded, based upon the terms of sales contracts, in the same period the related sales are recorded, as a deduction to the sale. Sales discounts and rebates are offered to certain customers to promote customer loyalty and encourage greater product sales.
Components of Cost of Sales - Cost of sales is comprised of raw material costs including freight and duty, inbound handling costs associated with the receipt of raw materials, contract manufacturing costs, third party bottling and packaging, maintenance and storage costs, plant and engineering overhead allocation, terminals and other warehousing costs, and handling costs.
Selling Expenses - Included in selling and general administrative expenses are the commission expenses for both employees and outside sales representatives ranging from 1.5% to 11.5% per dollar of sales. The Company expends significant amounts to advertise and distinguish its products from those of its competitors through the use of in-store advertising, printed media, internet and broadcast media.
Research, Testing and Development - Research, testing and development costs are expensed as incurred. Research and development expenses, including testing, were $118,546 and $304,793 for the years ended March 31, 2008 and 2007, respectively. Costs to acquire in-process research and development (IPR&D) projects that have no alternative future use and that have not yet reached technological feasibility at the date of acquisition are expensed upon acquisition.
Income Taxes - We provide for income taxes in accordance with SFAS No. 109, “Accounting for Income Taxes.” SFAS No. 109 requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts and the tax bases of the assets and liabilities.
The recording of a net deferred tax asset assumes the realization of such asset in the future; otherwise a valuation allowance must be recorded to reduce this asset to its net realizable value. The Company considers future pretax income and, if necessary, ongoing prudent and feasible tax planning strategies in assessing the need for such a valuation allowance. In the event that the Company determines that it may not be able to realize all or part of the net deferred tax asset in the future, a valuation allowance for the deferred tax asset is charged against income in the period such determination is made. The Company has recorded full valuation allowances as of March 31, 2008 and 2007.
Concentrations of Credit Risks —Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. Although the amount of credit exposure to any one institution may exceed federally insured amounts, the Company limits its cash investments to high-quality financial institutions in order to minimize its credit risk. With respect to accounts receivable, such receivables are primarily from distributors and retailers located in the United States and foreign distributors. The Company extends credit based on an evaluation of the customer's financial condition, generally without requiring collateral. Exposure to losses on receivables is dependent on each customer's financial condition. At March 31, 2008, the amounts due from two foreign distributors were $745,952, which represents 79.9% of accounts receivable.
Segment Information
We operate in one industry segment, the development, manufacture and sale of private and commercial vehicle energy efficient enhancement products. These products are designed to extend engine life, promote fuel efficiency and reduce emissions. At March 31, 2008 these products are being marketed by the Company and sales were predominantly in the United States of America, Canada, Mexico and Nigeria.
New accounting pronouncements:
GAAP Hierarchy
In May 2008, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 162, "The Hierarchy of Generally Accepted Accounting Principles." SFAS No. 162 identifies the sources of accounting principles and the framework for selecting the principles used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles (the GAAP hierarchy). SFAS No. 162 will become effective 60 days following the SEC's approval of the Public Company Accounting Oversight Board amendments to AU Section 411, "The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles." EMTA does not expect the adoption of SFAS No. 162 to have a material effect on its results of operations and financial position.
Convertible Debt
In May 2008, the FASB issued Financial Statement Position (FSP) Accounting Principles Board (APB) 14-1 "Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)." FSP APB 14-1 requires the issuer of certain convertible debt instruments that may be settled in cash (or other assets) on conversion to separately account for the liability (debt) and equity (conversion option) components of the instrument in a manner that reflects the issuer's non-convertible debt borrowing rate. FSP APB 14-1 is effective for fiscal years beginning after December 15, 2008 on a retroactive basis and will be adopted by EMTA in the first quarter of fiscal 2010. EMTA is currently evaluating the potential impact, if any, of the adoption of FSP APB 14-1 on its results of operations and financial position.
Noncontrolling Interests
In December 2007, the FASB issued SFAS No. 160, "Noncontrolling Interests in Consolidated Financial Statements—an amendment of Accounting Research Bulletin No. 51." SFAS No. 160 establishes accounting and reporting standards for ownership interests in subsidiaries held by parties other than the parent, the amount of consolidated net income attributable to the parent and to the noncontrolling interest, changes in a parent's ownership interest, and the valuation of retained noncontrolling equity investments when a subsidiary is deconsolidated. SFAS No. 160 also establishes disclosure requirements that clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners. SFAS No. 160 is effective for fiscal years beginning after December 15, 2008 and will be adopted by the Company in the first quarter of fiscal 2010. We do not expect the adoption of SFAS No. 160 to have a material effect on its results of operations and financial position.
Fair Value Option
In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option for Financial Assets and Financial Liabilities—Including an Amendment of FASB Statement No. 115," which permits an entity to measure many financial assets and financial liabilities at fair value that are not currently required to be measured at fair value. Entities that elect the fair value option will report unrealized gains and losses in earnings at each subsequent reporting date. The fair value option may be elected on an instrument-by-instrument basis, with few exceptions. SFAS No. 159 amends previous guidance to extend the use of the fair value option to available-for-sale and held-to-maturity securities. The statement also establishes presentation and disclosure requirements to help financial statement users understand the effect of the election. This statement is effective for fiscal years beginning after November 15, 2007. EMTA does not expect the adoption of SFAS No. 159 to have a material effect on its results of operations and financial position.
Fair Value Measurements
In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements." SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. This statement applies under other accounting pronouncements that require or permit fair value measurement where the FASB has previously determined that under those pronouncements fair value is the appropriate measurement. This statement does not require any new fair value measurements but may require companies to change current practice. This statement is effective for fiscal years beginning after November 15, 2007. EMTA does not expect the adoption of SFAS No. 157 to have a material effect on its results of operations and financial position.
Defined Benefit Pension and Other Postretirement Plans
In September 2006, the FASB issued SFAS No. 158, "Employers' Accounting for Defined Benefit Pension and Other Postretirement Plans." SFAS No. 158 requires employers to fully recognize the obligations associated with single-employer defined benefit pension, retiree healthcare, and other postretirement plans in their financial statements. The effect of adopting SFAS No. 158 on EMTA's financial statements at March 31, 2007 and 2008 has no effect on the Company.
Split-Dollar Life Insurance Arrangements
In September 2006, the Emerging Issues Task Force (EITF) reached consensus on EITF Issue No. 06-4, "Accounting for Deferred Compensation and Postretirement Benefit Aspects of Endorsement Split-Dollar Life Insurance Arrangements." The scope of EITF No. 06-4 is limited to the recognition of a liability and related compensation costs for endorsement split-dollar life insurance arrangements that provide a benefit to an employee that extends to postretirement periods. EITF No. 06-4 is effective for fiscal years beginning after December 15, 2007. We adopted EITF No. 06-4 early, in fiscal 2008, and its adoption did not have an impact on EMTA’s results of operations or financial position.
In June 2006, the FASB issued FASB Interpretation (FIN) No. 48, "Accounting for Uncertainty in Income Taxes," which supplements SFAS No. 109, "Accounting for Income Taxes,' and is effective for fiscal years beginning after December 15, 2006. FIN 48 clarifies the accounting for uncertainties in income taxes recognized in accordance with SFAS 109 by prescribing guidance for the recognition, de-recognition, and measurement in financial statements of income tax positions taken in previously filed tax returns or tax positions expected to be taken in tax returns, including a decision whether to file or not to file in a particular jurisdiction. FIN 48 requires that any liability created for unrecognized tax benefits be disclosed. The application of FIN 48 may also affect the tax bases of assets and liabilities and therefore may change or create deferred tax liabilities or assets.
On March 31, 2007, we adopted the provisions of FIN 48. There was no material impact to EMTA of adopting FIN 48.
Life Insurance Policies
In March 2006, the FASB issued FSP No. FTB 85-4-1, "Accounting for Life Settlement Contracts by Third Party Investors." FSP FTB 85-4-1 provides for a contract-by-contract irrevocable election to account for life settlement contracts on either a fair value basis, with changes in fair value recognized in the condensed consolidated statements of operations, or through use of the investment method. Under the investment method, the initial investment and continuing costs are capitalized; however, no income is recognized until the death of the insured party. The guidance of FSP FTB 85-4-1 will be effective for fiscal years beginning after June 15, 2006. EMTA adopted FSP FTB 85-4-1 as of the beginning of fiscal 2008, and its adoption did not have an impact on EMTA’s results of operations or financial position.
In September 2006, the EITF reached a conclusion on EITF Issue No. 06-5, "Accounting for Purchases of Life Insurance—Determining the Amount That Could Be Realized in Accordance with FASB Technical Bulletin No. 85-4, "Accounting for Purchases of Life Insurance." The scope of EITF No. 06-5 consists of three separate issues relating to accounting for life insurance policies purchased by entities protecting against the loss of "key persons." The three issues are clarifications of previously issued guidance on FASB Technical Bulletin No. 85-4. EMTA adopted EITF No. 06-5 as of the beginning of fiscal 2008, and its adoption did not have a material impact on EMTA’s results of operations or financial position.
Litigation - The Company is and may become a party in routine legal actions or proceedings in the ordinary course of its business. The Company is a defendant in one case for the payment of advertising costs in which the Company does not believe that the services were adequately performed. Management does not believe that the outcome of these routine matters will have a material adverse effect on the Company's consolidated financial position or results of operations.
Environmental —The Company's operations are subject to extensive federal, state and local laws, regulations and ordinances in the United States relating to the generation, storage, handling, emission, transportation and discharge of certain materials, substances and waste into the environment, and various other health and safety matters. Governmental authorities have the power to enforce compliance with their regulations, and violators may be subject to fines, injunctions or both. The Company must devote substantial financial resources to ensure compliance, and it believes that it is in substantial compliance with all the applicable laws and regulations.
Note 3 - Inventories
Inventory consists of finished goods, work in process and raw material as follows:
| | March 31, 2008 | | | March 31, 2007 | |
| | | | | | | | |
Finished goods | | $ | 340,087 | | | $ | 471,173 | |
Raw material | | | 76,706 | | | | 115,280 | |
| | $ | 416,793 | | | $ | 586,453 | |
At March 31, 2008 and 2007 equipment and computers consisted of the following:
| | March 31, 2008 | | | March 31, 2007 | |
| | | | | | | | |
Property and plant | | $ | 1,442,401 | | | $ | 1,467,729 | |
Equipment and computers | | | 518,504 | | | | 600,845 | |
Less accumulated depreciation | | | (173,938 | ) | | | (32,666 | ) |
Net equipment and Computers | | $ | 1,786,967 | | | $ | 2,035,908 | |
During the years ended March 31, 2008 and 2007 depreciation and amortization expense was $121,046 and $27,943, respectively.
During the year the carrying value of assets acquired from Dyson were reduced by $119,760 in accordance with the Purchase Agreement.
Note 5 - Intangible Assets
Intangible assets consist of technology of production and license rights under the Environmental Protection Agency to market one of the products acquired in the acquisition of White Sands, L.L.C. on March 31, 2006. The Company intends to market the related products as soon as production and marketing strategies can be completed. The Company is amortizing this investment over its estimated useful life of seven years on a straight line basis. For the year ended March 31, 2008 and March 31, 2007 amortization was $126,722 in each year.
Note 6 - Accrued Liabilities
Accrued liabilities consist of the following as of March 31, 2008 and 2007:
| | March 31, 2008 | | | March 31, 2007 | |
| | | | | | | | |
Accrued marketing and advertising | | $ | 300,000 | | | $ | 300,000 | |
Accrued reimbursement to product testing partner | | | 978,151 | | | | 978,151 | |
Accrued interest | | | 288,046 | | | | 98,788 | |
Other | | | 91,219 | | | | 19,124 | |
| | $ | 1,657,416 | | | $ | 1,396,063 | |
As part of our testing of products and new applications the Company agreed to reimburse one of our testing partners for the costs incurred in such testing.
Note 7 - Notes and Contracts Payable
Bank Loans, payable in installments | | $ | 287,943 | |
Mortgage Loan Payable, monthly payments of principal and interest at 3 month LIBOR plus 4.7%. (1) | | | 807,062 | |
Payments due seller of Dyson | | | 254,240 | |
Loan from Dyson | | | 35,000 | |
Notes payable | | | 1,027,851 | |
Loans from individuals, due within one year | | | 258,000 | |
| | | 2,670,096 | |
Less amounts due within one year | | | 1,795,398 | |
Amounts due after one year | | $ | 874,698 | |
____________
(1) | In conjunction with the acquisition of Dyson, the mortgage became payable as a result of the change of control of that company. The Company is in the process of refinancing the property. |
Bank Loans consist of two loans that became due in the first quarter of 2009; these loans are secured by receivables, inventory and equipment in Durant, Oklahoma. The Company is working to replace these loans. The Mortgage Loan Payable has matured as a result of the change in control of the operations in Durant. The Company continues to make principal and interest payments while the Company obtains a replacement loan on the property. Interest is reset quarterly at Libor + 4.7%.
The amounts due sellers bear interest at a rate of 8.0% and is due in July, 2008.
Notes payable include Amounts due after one year conists of the the loan from Shelter Island Opportunity Fund with interst at 12.25% per annum and secured by the plant and equipment in Durant, Oklahoma. Maturities for the remainder of the loan are as follows:
2009 | | $ | 125,399 | |
2010 | | $ | 217,400 | |
2011 | | $ | 657,298 | |
The balance of the notes payable consist of commercial loans of a vehicles and equipment in the normal course of business.
The Loans from individuals includes three loans are all due within one year and bear intersest from 9% to 12%.
Note 8 - - Income Taxes
Through March 31, 2008, we recorded a valuation allowance of $4,610,750 against deferred income tax assets primarily associated with tax loss carry forwards. Our significant operating losses experienced in prior years establishes a presumption that realization of these income tax benefits does not meet a “more likely than not” standard.
We have net operating loss carry forwards of approximately $11,960,771. Our net operating loss carry forwards will expire between 2025 and 2028.
Significant components of our deferred tax assets and liabilities at the balance sheet dates were as follows:
| March 31, | |
| 2008 | | 2007 | |
Deferred Tax Assets and Liabilities | | | | |
Deferred tax assets: | | | | |
Net operating loss carryforwards | | $ | 4,594,546 | | | $ | 3,725,691 | |
Allowance for doubtful accounts | | | 16,204 | | | | 16,187 | |
Total | | | 4,610,750 | | | | 3,741,878 | |
Less: Valuation allowance | | | (4,610,750 | ) | | | (3,741,878 | ) |
Total deferred tax assets | | | – | | | | – | |
Total deferred tax liabilities | | | – | | | | – | |
Net deferred tax liabilities | | $ | – | | | $ | – | |
| Fiscal Years Ended March 31, | |
| 2008 | | 2007 | |
Reconciliation | | | | |
Income tax credit at statutory rate | | $ | (765,364 | ) | | $ | (1,043,248 | ) |
Effect of state income taxes | | | (103,508 | ) | | | (129,164 | ) |
Valuation allowance | | | 868,872 | | | | 1,172,412 | |
Income taxes (credit) | | $ | – | | | $ | – | |
Future realization of the net operating losses is dependent on generating sufficient taxable income prior to their expiration. Tax effects are based on a 34% Federal income tax rate. The net operating losses expire as follows:
| | Amount | |
Expiration | | | | |
2025 | | $ | 1,524,541 | |
2026 | | | 5,132,298 | |
2027 | | | 3,052,902 | |
2028 | | | 2,251,030 | |
Total net operating loss available | | $ | 11,960,771 | |
Note 9 - Convertible Debt and Conversion Share Derivative Liability
The Company entered into a Convertible Loan Agreement which entitled the lenders to warrants and convert the loans at their option to common stock of the Company. The face value of the Convertible Notes, 6%, interest quarterly to March 31, 2008 was as follows:
Maturity | | Amount | | | Exercised | | | Balance | |
| | | | | | | | | |
April 28, 2009 | | $ | 414,894 | | | $ | 100,200 | | | $ | 314,694 | |
August 17, 2009 | | | 648,563 | | | | – | | | | 648,563 | |
October 28, 2009 | | | 297,398 | | | | – | | | | 297,398 | |
November 10, 2009 | | | 1,102,160 | | | | – | | | | 1,102,160 | |
Total | | $ | 2,463,015 | | | $ | 100,200 | | | $ | 2,362,815 | |
The lenders were issued warrants to purchase 7,000,000 shares of common stock at an exercise price of $2.50 per share. The Company also issued warrants to a broker in the transaction for the exercise of 700,000 shares of common stock at an exercise price of $2.50. These warrants expire if not exercised at various dates in 2013 through November 10, 2013. All of the 7,700,000 warrants have been issued entitling the lender to one share for each warrant at an exercise price of $2.50 per share.
The agreements include registration rights and certain other terms and conditions related to share settlement of the embedded conversion features and the warrants. In this instance, EITF 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock”, requires allocation of the proceeds between the various instruments and the derivative elements carried at fair values.
As a result of the Company not having filed the registration statement within 30 days of the execution of the loan agreement, the parties agreed that the Company would issue warrants to purchase an additional 5,000,000 shares of the Company’s common stock at $2.50 per share. The warrants expire if not exercised on August 10, 2013. These warrants were issued to cure the default that occurred on June 28, 2006 and was executed on August 10, 2006. The Company recorded the fair value of these warrants as loan default costs as of June 28, 2006.
Note 10 - - Commitments and contingencies
Concentration of Credit Risk
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash. The Company periodically evaluates the credit worthiness of financial institutions, and maintains cash accounts only in large high quality financial institutions, thereby minimizing exposure for deposits in excess of federally insured amounts.
Lease Commitments
The Company has a lease agreement for office space in Scottsdale, Arizona. The remaining lease commitment is for 3 years with annual payments as follows:
2009 | | $ | 75,793 | |
2010 | | | 78,067 | |
2011 | | | 80,409 | |
2012 | | | 6,717 | |
| | $ | 240,986 | |
Note 11 - Accounting for derivative financial instruments
In April 29, 2006, the Company entered into an agreement whereby it would issued 6% secured convertible notes in the aggregate principal amount of $3,000,000 which are convertible into common shares of the Company at the lender’s option based on a rate of 50% of the then current market price at the time of the conversion election. The Company has the right at any time that the stock is trading below $5.00 per share to call the notes at a prepayment premium of 130% of the outstanding balance. The Company has reserved a sufficient number of its common shares to meet these obligations.
The consolidated financial statements for the year ended March 31, 2007 has recognize all features of the derivative financial instruments including the host instruments, the embedded conversion features and the free-standing warrants in accordance with Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities” (“SFAS 133”) and EITF 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” (“EITF 00-19”).
The proceeds from each financing arrangement were allocated to the various elements of the financing resulting in discounts to the face values of the debt instruments. These discounts were then amortized over the debt terms (in all instances three-years) using the effective interest method.
Free-standing warrants:
Proceeds from the financing were allocated to the fair value of the warrants issued using the binomial model. These instruments will be carried as additional paid in capital, and their carrying values will not be adjusted to fair value at the end of each subsequent reporting period.
Free standing instruments, consisting of warrants, are valued using the binomial model valuation methodology because that model embodies all of the relevant assumptions that address the features underlying these instruments.
Significant assumptions included in this model as of March 31, 2008 are as follows:
| | Original | | | Default | |
| | Warrants | | | Warrants | |
| | | | | | | | |
Exercise price | | $ | 2.50 | | | $ | 2.50 | |
Shares subject to exercise | | | 7,000,000 | | | | 5,000,000 | |
Weighted Average Term Remaining (years) | | | 5.41 | | | | 5.25 | |
Volatility | | | 115.8 | % | | | 115.8 | % |
Risk-free rate | | | 1.55-2.46 | % | | | 1.55-2.46 | % |
Implied value | | $ | 945,809 | | | $ | 658,123 | |
Recorded value | | $ | – | | | $ | 13,960,334 | |
The value of the original warrants was limited by the net loan amounts and debt conversion value after issue costs.
Embedded conversion features:
Each hybrid instrument was analyzed in accordance with the guidance in SFAS 133 for features that possessed the characteristics of derivative instruments. Those instruments whose economic characteristics and risks of the embedded derivative instrument were not “clearly and closely related” to the host instrument were bifurcated and treated as derivatives under the guidance of SFAS 133 and recorded at fair value with adjustments to fair value at the end of each subsequent reporting period. This resulted in the conversion feature being recorded as an embedded derivative at each loan funding date, April 29, 2006, August 17, 2006, October 28, 2006 and November 10, 2006.
Summary:
As a result of the above at March 31, 2008 the balances were as follows:
| | Liability | | | Expense | |
| | | | | | | | |
Original Warrants | | $ | – | | | $ | – | |
Conversion feature | | | 2,362,815 | | | | 296,944 | |
| | | | | | | | |
Total | | $ | 2,362,815 | | | $ | 296,944 | |
Note 12 - - Company Stock
Preferred Stock
At March 31, 2008 and 2007, the Company had 1,000,000 shares of $0.001 par value authorized and no outstanding or issued shares.
Common Stock
At March 31, 2008 and 2007, the Company had 250,000,000 shares authorized of $0.001 par value common stock, of which issued and outstanding shares were 54,885,103 and 40,396,004, respectively.
Warrants
In conjunction with four fundings during the year ended March 31, 2007, the Company issued 7,000,000 warrants at an exercise price of $2.50 per share and 5,000,000 warrants to cure a default caused by late filing of the registration statement with the Securities and Exchange Commission and 700,000 cashless warrants to the broker that brought the loan packages to the Company. All of these warrants expire seven years from issue.
Also, the Company issued 1,400,000 cashless warrants to the seller in conjunction with the acquisition of Dyson Properties, Inc. that expire three years from issue.
During the year ended March 31, 2008 the Company issued 5,775,000 warrants at an exercise price of $0.75 per share and 519,750 shares cashless warrants at an exercise price of $0.75 for a period of 5 years in conjunction with a loan funding in June of 2007. The Company also issued warrants to purchase 500,000 shares at an exercise price of $0.75 for a term of two years in conjunction with the investors purchase of common stock.
At March 31, 2008 the status of outstanding warrants is as follows:
| | Shares Exercisable | | Weighted Average Exercise Price | | Expiration Date |
| | | | | | | |
September 27, 2005 | | 450,000 | | $ | 2.50 | | September 26,2010 |
April 29, 2006 | | 1,866,667 | | $ | 2.50 | | April 28, 2013 |
June 28, 2006 | | 5,000,000 | | $ | 2.50 | | August 10, 2013 |
August 17, 2006 | | 1,633,333 | | $ | 2.50 | | August 17, 2013 |
October 28, 2006 | | 700,000 | | $ | 2.50 | | October 28, 2013 |
November 10, 2006 | | 2,800,000 | | $ | 2.50 | | November 10, 2013 |
May 21, 2007 | | 500,000 | | $ | .75 | | May 20, 2009 |
July 1, 2007 | | 5,775,000 | | $ | .75 | | June 30, 2012 |
Cashless April 20-November 10, 2006 | | 700,000 | | $ | 2.50 | | April 29 - November 10, 2015 |
Cashless March 26, 2007 | | 1,400,000 | | $ | .75 | | March 26, 2010 |
Cashless July 1, 2007 | | 519,750 | | $ | .75 | | June 30, 2012 |
The warrants have no intrinsic value at March 31, 2008.
Stock Options
At March 31, 2008, the Company had one stock option plan under which grants were outstanding. The stock options outstanding are for grants issued under the Company’s 2007 Stock Incentive Plan.
The 2007 Stock Incentive Plan
During the fiscal year ended March 31, 2008, the Company adopted a stock option plan, entitled the “2007 Incentive Plan” (the “2007 Plan”), under which the Company may grant options to purchase up to 20,000,000 shares of common stock.
The 2007 Plan is are administered by the Board of Directors or a Committee of the Board of Directors which has the authority to determine the persons to whom the options may be granted, the number of shares of common stock to be covered by each option grant, and the terms and provisions of each option grant. Options granted under the 2007 Plan may be incentive stock options or non-qualified options, and may be issued to employees, consultants, advisors and directors of the Company and its subsidiaries. The exercise price of options granted under the 2007 Plan may not be less than the fair market value of the shares of common stock on the date of grant, and may not be granted more than ten years from the date of adoption of the plan or exercised more than ten years from the date of grant.
The following table sets forth the Company’s stock option activity during the year ended March 31, 2008:
| | Shares Underlying Options | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Life | | Aggregate Intrinsic Value |
| | | | | | | | | |
Outstanding at March 31, 2007 | | | | $ | – | | – | | – |
Granted | | 5,415,000 | | $ | .20 | | 3.0 | | – |
Exercised | | | | | – | | – | | – |
Canceled | | | | | – | | – | | – |
| | | | | | | | | |
Outstanding at March 31, 2008 | | 5,415,000 | | $ | .20 | | 3.0 | | – |
| | | | | | | | | |
Exercisable at March 31, 2008 | | | | $ | – | | – | | |
| | Number of Options | | | Weighted-Average Grant-Date Fair Value | |
| | | | | | | | |
Non-vested as of March 31, 2007 | | | 0 | | | $ | – | |
Granted | | | 5,415,000 | | | | .11 | |
Forfeited | | | (0 | ) | | | – | |
Vested | | | (0 | ) | | | – | |
| | | | | | | | |
Non-vested as of March 31, 2008 | | | 5,415,000 | | | $ | .11 | |
During the year ended March 31, 2008, the Company granted options to purchase an aggregate of 5,415,000 shares of common stock to employees, directors and consultants for services to be provided. These options are exercisable at $0.20 per share, and vest one third on October 1, 2008, April 1, 2009 and October 1, 2009 with an expiration of three years from the date of grant for all options. The Company has valued these at their fair value on the date of grant using the Hull-White enhanced option-pricing model.
Unrecognized stock-based compensation expense related to the unvested options is approximately $610,548 and will be recorded over the vesting periods of 18 months. This estimate is based on the number of unvested options currently outstanding and could change based on the number of options granted or forfeited in the future. These options have no intrinsic value at March 31, 2008.
The assumptions used in calculating the fair value of stock-based payment awards represent management’s best estimates.
The Company based its expected volatility on the historical volatility of similar companies with consideration given to the expected life of the award. The Company intends to continue to consistently use this method until sufficient market acceptance of its stock has reached a stable level.
The risk-free interest rate used for each grant is equal to the U.S. Treasury yield in effect at the time of grant for instruments with a similar expected life.
The expected term of options granted was determined based on the historical exercise behavior of similar peer groups.
The Company has never declared or paid a cash dividend, and has no current plans to pay a cash dividend in the future.
SFAS 123(R) also requires that the Company recognize compensation expense for only the portions that are expected to vest. Therefore, the Company has estimated expected forfeitures of stock options with the adoption of SFAS 123(R). In developing a forfeiture rate estimate, the Company considered its historical experience. If the actual number of forfeitures differs from those estimated by management, additional adjustments to compensation expense may be required in future periods.
The fair value of options were estimated at the date of grant with the following weighted-average assumptions for the fiscal years ended March 31, 2008:
| | 2008 |
| | |
Risk Free Interest Rate | | | 1.79 | % |
Expected Life | | 3.0 years |
Expected Volatility | | | 116 | % |
Expected Dividend Yield | | | 0 | % |
The per share weighted average fair value of stock options granted for the fiscal year ended March 31, 2008 was $0.11.
Note 13 - - Earnings (Loss) Per Share
Basic income (loss) per common share is computed by dividing the results of operations by the weighted average number of shares outstanding during the period. For purposes of the determining the number of shares outstanding the shares received by the acquirer in the reverse acquisition are treated as outstanding for all periods prior to the transaction.
Diluted income (loss) earnings per common share adjusts basic income (loss) per common share for the effects of convertible securities, stock options, warrants and other potentially dilutive financial instruments only in periods in which such effect is dilutive. No instruments were dilutive at March 31, 2008 or 2007.
Note 14 – Subsequent Events
Sales of unregistered common stock – Subsequent to March 31, 2008 the Company completed the remainder of the offering and issued an additional 1,656,000 shares of common stock for gross proceeds of $207,000.
Issuance of shares for future services – In conjunction with consulting contracts to third parties the company issued 3,600,000 shares of restricted common stock. The contracts are for one and two years.
The company issued 300,000 shares of its restricted common stock in conjunction with the evaluation of a possible acquisition target.